{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:12:22Z","timestamp":1765545142123},"reference-count":4,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychosomatics"],"published-print":{"date-parts":[[2001,3]]},"DOI":"10.1176\/appi.psy.42.2.163-a","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:02:52Z","timestamp":1034359372000},"page":"163-164","source":"Crossref","is-referenced-by-count":11,"title":["Can Sertraline Induce Parkinson\u2019s Disease?"],"prefix":"10.1016","volume":"42","author":[{"given":"Robert J.","family":"Gregory","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason F.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1176\/appi.psy.42.2.163-a_bib0005","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0278-5846(98)00036-0","article-title":"Extrapyramidal adverse effects associated with sertraline","volume":"22","author":"Lambert","year":"1998","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1176\/appi.psy.42.2.163-a_bib0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s007020050053","article-title":"Sertraline induced parkinsonism. A case report and in-vivo study of the effect of sertraline on dopamine metabolism","volume":"105","author":"Di Rocco","year":"1998","journal-title":"J Neural Transm"},{"key":"10.1176\/appi.psy.42.2.163-a_bib0015","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4088\/JCP.v60n0611d","article-title":"SSRI-induced parkinsonism may be an early sign of future Parkinson\u2019s Disease","volume":"60","author":"Gonul","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1176\/appi.psy.42.2.163-a_bib0020","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/archpsyc.57.5.449","article-title":"Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine","volume":"57","author":"Gilbert","year":"2000","journal-title":"Arch Gen Psychiatry"}],"container-title":["Psychosomatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318201705440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318201705440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T16:25:22Z","timestamp":1554999922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033318201705440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":4,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["S0033318201705440"],"URL":"https:\/\/doi.org\/10.1176\/appi.psy.42.2.163-a","relation":{},"ISSN":["0033-3182"],"issn-type":[{"value":"0033-3182","type":"print"}],"subject":[],"published":{"date-parts":[[2001,3]]}}}